Genetic studies suggest a role for the innate immune system in disease pathogenesis, suggesting further future targets for biological therapies over the next few years. Therapeutic Advances in Musculoskeletal Disease, 2013 August; 5(4): 234–249. (Also see: Connective Tissue Disease)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.